Atropine, engaging with science and responsible practice – with Prof Karla Zadnik

Published: July 29th 2020

Professor Karla Zadnik, Dean of the Ohio State University College of Optometry in the USA, guides us through a variety of fascinating topics. In her capacity as Principal Investigator of the Childhood Atropine for Myopia Progression (CHAMP) study, Karla explains this multi-site, four year clinical trial which is investigating two proprietary formulations manufactured by US-based specialty pharmaceutical company Nevakar. I learnt that Nevakar is derived from Sanskrit, meaning ‘new form’, which is an ideal encapsulation of what we still need to learn about atropine. Karla advocates for you to engage directly with the volume of primary literature sources on myopia factors and interventions, to help you best translate that to management of the child in your chair. As Study Chair for the 11-year-long the Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) Study which generated a notable volume of research on myopia factors, I ask Karla to choose her favourite CLEERE papers. Finally, Karla’s view on myopia management in practice takes into account the potential race- and socioeconomic-based health disparities which could be created when myopia control is declared a standard of care. Karla provides us with important food for thought and a call to life-long learning.

Meet the Authors:

About Kate Gifford

Nulla placerat tempus lorem a viverra. Donec ullamcorper pretium urna, id faucibus sem vehicula eu. In interdum metus et lorem dapibus quis luctus mauris dictum. Nunc vel velit dui, non posuere velit. Etiam mauris nisl, hendrerit vel volutpat dapibus, tempor quis velit. Sed non sem eros. Integer tellus quam, hendrerit sed gravida in, congue a nisi. Aliquam dictum iaculis nisi vel eleifend. Sed vel erat et elit fermentum euismod. Phasellus convallis ornare dolor, non luctus libero tincidunt aliquet. Donec tortor neque, porta tempor pharetra nec, rhoncus eget lectus. Proin sit amet leo arcu. In odio neque, aliquam eu auctor quis, rutrum ac lectus. Vestibulum ac nisi diam, non molestie ligula. Ut ullamcorper lectus eu nisi semper suscipit. In placerat imperdiet magna, in imperdiet nisl vulputate ultricies. Nunc nibh orci, ultrices id pretium non, semper sed lacus. Vivamus id purus adipiscing lorem venenatis pellentesque. Nunc viverra aliquam scelerisque. Nam in nibh id ante pulvinar tempor quis vel risus. Fusce mattis feugiat dignissim. Cras massa nisi, convallis et laoreet ac, facilisis pellentesque risus.